| 11964961 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2024-04-23 |
$398,665,000 |
| 11014909 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2021-05-25 |
$425,301,000 |
| 10696658 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2020-06-30 |
$597,435,000 |
| 10421744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2019-09-24 |
$287,330,000 |
| 10093655 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2018-10-09 |
$408,783,000 |
| 10077272 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, Chewah Lee +4 more |
2018-09-18 |
$396,134,000 |
| 9868744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, Chewah Lee +4 more |
2018-01-16 |
$592,962,000 |
| 9856263 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, Scot Richard Mente, Chakrapani Subramanyam |
2018-01-02 |
$562,360,000 |
| 9822097 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2017-11-21 |
$292,923,000 |
| 9688698 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, Scot Richard Mente +1 more |
2017-06-27 |
$681,026,000 |
| 9617275 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jotham Wadsworth Coe, John Arthur Allen, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray +9 more |
2017-04-11 |
$241,476,000 |
| 9527843 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Scot Richard Mente, Steven Victor O'Neil +3 more |
2016-12-27 |
$413,344,000 |
| 9527831 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2016-12-27 |
$413,344,000 |
| 9139561 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2015-09-22 |
$161,915,000 |
| 9133190 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Scot Richard Mente, Steven Victor O'Neil +3 more |
2015-09-15 |
$290,120,000 |
| 9107923 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green +6 more |
2015-08-18 |
$621,732,000 |
| 8933095 |
KAT II inhibitors |
Laura Ann McAllister, Vinod Parikh, Suobao Rong, Patrick Robert Verhoest |
2015-01-13 |
$137,387,000 |
| 8822494 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Scot Richard Mente, Steven Victor O'Neil +3 more |
2014-09-02 |
$96,406,000 |
| 8598200 |
KAT II inhibitors |
Laura Ann McAllister, Vinod Parikh, Suobao Rong, Patrick Robert Verhoest |
2013-12-03 |
$216,064,000 |
| 8487104 |
KAT II inhibitors |
Christopher John Helal, Jamison Bryce Tuttle, Patrick Robert Verhoest |
2013-07-16 |
$331,538,000 |
| 8183238 |
Bicyclic and tricyclic compounds as KAT II inhibitors |
Michelle Marie Claffey, Matthew Merrill Hayward, Suobao Rong, Patrick Robert Verhoest, Jamison Bryce Tuttle +1 more |
2012-05-22 |
$139,115,000 |
